Insmed Incorporated
INSM
Peringkat dalam Saham
#1109
Insmed Incorporated operates as a biopharmaceutical enterprise focused on... Insmed Incorporated operates as a biopharmaceutical enterprise focused on creating and introducing medical solutions for individuals facing severe and uncommon health conditions. The company's marketed treatment, ARIKAYCE, is administered to adult patients suffering from Mycobacterium avium complex (MAC) lung disease, serving as a component of a broader antibacterial drug regimen. In its development pipeline, Insmed is advancing Brensocatib, an oral and reversible inhibitor targeting dipeptidyl peptidase 1, which is being investigated for its potential in treating bronchiectasis and other disorders mediated by neutrophils. Additionally, the firm is developing Treprostinil Palmitil Inhalation Powder, an inhaled version of the treprostinil palmitil prodrug, designed to address pulmonary arterial hypertension and various other rare lung ailments. Founded in 1988, Insmed Incorporated maintains its primary corporate offices in Bridgewater, New Jersey.
Harga Saham
$95.88
Kapitalisasi Pasar
$20.94B
Perubahan (1 hari)
0.61%
Perubahan (1 tahun)
-42.90%
Negara
US
Perdagangan Insmed Incorporated (INSM)
Kategori
Healthcare
Riwayat pemecahan saham untuk Insmed Incorporated (INSM)
Saham Insmed Incorporated (simbol: INSM) telah mengalami total 2 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Mar 03, 2011.
Satu lembar saham INSM yang dibeli sebelum Jul 31, 2000 sekarang setara dengan 0.025 lembar saham INSM.
Pemecahan saham terbaru terjadi pada Mar 03, 2011.
Satu lembar saham INSM yang dibeli sebelum Jul 31, 2000 sekarang setara dengan 0.025 lembar saham INSM.
Daftar pemecahan saham
| Tahun | Pemecahan | Kelipatan | Kelipatan Kumulatif |
|---|---|---|---|
| 2011-03-03 | 1:10 | x0.1 | x0.025 |
| 2000-07-31 | 1:4 | x0.25 | x0.25 |
Pemecahan saham untuk perusahaan sejenis atau pesaing
| Perusahaan | Jumlah pemecahan saham | Kelipatan Kumulatif | Negara |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
